In the Luminex xMAP analysis, the serum levels of CCL21 were higher in SSc patients than healthy controls (0.47 ± 0.81ng/ml vs. 0.21 ± 0.30ng/ml, p<0.001) (Figure 4A, ii), as we saw in ELISA1. This evidence concerns the gene CCL21 and systemic sclerosis.